Infection with a high dose of MCMV-IE2-E7 via the IP and SC route induced as expected stronger CD8+ T cell responses (> 0.3%) against the E7 epitope compared to inoculum dosages with 1000 fold less virus, which resulted in responses < 0.3% in the blood (Fig. 5b). This evidence concerns the gene CD8A and infection.